News + Filings Transactions
|
Lin Shao-Lee
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2023 | ACELYRIN, Inc. | | Other (disposition) | Common Stock | 1.2M | $0.00 | $0 | See footnote | 10/04/2023 |
| 10/04/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 132.2k | $0.00 | $0 | See footnote | 10/04/2023 |
| 08/16/2023 | ACELYRIN, Inc. | | Grant | Common Stock | 842.4k | $0.00 | $0 | | 08/16/2023 |
| 05/18/2023 | Surrozen, Inc./DE | | Grant | Option (right to buy) | 20k | $0.56 | $11.2k | | 05/18/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 355k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Class A Common Stock | 349.9k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 349.9k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Class A Common Stock | 5.1k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 677.8k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Class A Common Stock | 677.8k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Payment of Exercise | Common Stock | 337.2k | $24.69 | $8.3M | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 1.1M | $0.00 | $0 | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Class A Common Stock | 1.1M | $0.00 | $0 | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Common Stock | 1.2M | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 5.1k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Series B Redeemable Convertible Preferred Stock | 978.3k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Series C Redeemable Convertible Preferred Stock | 183.4k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Employee Stock Option (right to buy) | 774.8k | $18.00 | $13.9M | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Employee Stock Option (right to buy) | 774.8k | $18.00 | $13.9M | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Class A Common Stock | 355k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Common Stock | 355k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Class A Common Stock | 355k | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/04/2023 | ACELYRIN, Inc. | | Grant | Employee Stock Option (right to buy) | 774.8k | $18.00 | $13.9M | | 05/04/2023 |
| 06/07/2022 | Surrozen, Inc./DE | | Grant | Option (right to buy) | 20k | $2.79 | $55.8k | | 06/07/2022 |
| 09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Director Stock Option (right to buy) | 20.5k | $27.81 | $569.4k | | 09/28/2020 |
| 09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Director Stock Option (right to buy) | 10.2k | $31.77 | $325.3k | | 09/28/2020 |
| 09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Director Stock Option (right to buy) | 10.2k | $62.66 | $641.6k | | 09/28/2020 |
| 06/04/2020 | Principia Biopharma Inc. | PRNB | Grant | Director Stock Option (right to buy) | 10.2k | $62.66 | $641.6k | | 06/04/2020 |
| 01/21/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Grant | Ordinary Shares | 6.1k | $0.00 | $0 | | 01/21/2020 |
| 01/21/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Payment of Exercise | Ordinary Shares | 2.7k | $38.25 | $103.9k | | 01/21/2020 |
| 01/21/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Grant | Performance Restricted Stock Units (PSUs) | 12.3k | $0.00 | $0 | | 01/21/2020 |
| 01/05/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Grant | Ordinary Shares | 35.7k | $0.00 | $0 | | 01/03/2020 |
| 01/05/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Payment of Exercise | Ordinary Shares | 38.1k | $36.10 | $1.4M | | 01/03/2020 |
| 01/05/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Exercise | Restricted Stock Units (RSU) | 18k | $0.00 | $0 | | 01/03/2020 |
| 01/05/2020 | Horizon Therapeutics Public Ltd Co | HZNP | Exercise | Restricted Stock Units (RSU) | 32.4k | $0.00 | $0 | | 01/03/2020 |
|
|